Lactic acid bacteria having mucosal immunopotentiation effect

Details for Australian Patent Application No. 2004267304 (hide)

Owner Otsuka Pharmaceutical Co., Ltd.

Inventors Toba, Masamichi; Yamahira, Satoko; Okamatsu, Hiroshi

Agent Freehills

Pub. Number AU-B-2004267304

PCT Pub. Number WO2005/019438

Priority 2003-297570 21.08.03 JP

Filing date 18 August 2004

Wipo publication date 3 March 2005

Acceptance publication date 12 March 2009

International Classifications

A23C 9/123 (2006.01) Dairy products

A23L 1/30 (2006.01) Foods or foodstuffs - containing additives

A61K 35/74 (2006.01) Medicinal preparations containing material or reaction products thereof with undetermined constitution

Event Publications

2 March 2006 PCT application entered the National Phase

  PCT publication WO2005/019438 Priority application(s): WO2005/019438

1 March 2007 Amendment Made

  The nature of the amendment is as shown in the statement(s) filed 06 Feb 2007 2004276321 HW Process Technologies, Inc. The nature of the amendment is as shown in the statement(s) filed 24 Apr 2006 and 25 May 2006

12 March 2009 Application Accepted

  Published as AU-B-2004267304

9 July 2009 Standard Patent Sealed

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2004267313-Process for producing cytotoxic lymphocytes

2004267301-Sound absorbing material